KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Sales (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Return on Sales for 11 consecutive years, with 0.19% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 3.0% year-over-year to 0.19%, compared with a TTM value of 0.64% through Dec 2025, up 45.0%, and an annual FY2025 reading of 0.18%, down 1.0% over the prior year.
  • Return on Sales was 0.19% for Q4 2025 at Medpace Holdings, down from 0.81% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.81% in Q3 2025 and bottomed at 0.13% in Q2 2023.
  • Average Return on Sales over 5 years is 0.22%, with a median of 0.17% recorded in 2022.
  • The sharpest move saw Return on Sales dropped -5bps in 2021, then soared 63bps in 2025.
  • Year by year, Return on Sales stood at 0.16% in 2021, then grew by 7bps to 0.17% in 2022, then decreased by -10bps to 0.16% in 2023, then surged by 39bps to 0.22% in 2024, then dropped by -13bps to 0.19% in 2025.
  • Business Quant data shows Return on Sales for MEDP at 0.19% in Q4 2025, 0.81% in Q3 2025, and 0.39% in Q2 2025.